Context-dependent regulation of receptor tyrosine kinases: Insights from systems biology approaches

被引:3
作者
Lam, Inez [1 ,2 ]
Pickering, Christina M. [1 ,2 ]
Mac Gabhann, Feilim [1 ,2 ,3 ,4 ]
机构
[1] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA
基金
美国国家科学基金会;
关键词
cell signaling; computational model; receptor tyrosine kinase; systems biology; GROWTH-FACTOR RECEPTOR; COMPUTATIONAL MODEL; BISPECIFIC ANTIBODY; SIGNALING NETWORK; VEGF ISOFORMS; CELL-SURFACE; MAP KINASE; IN-VIVO; EGF; TRAFFICKING;
D O I
10.1002/wsbm.1437
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Receptor tyrosine kinases (RTKs) are cell membrane proteins that provide cells with the ability to sense proteins in their environments. Many RTKs are essential to development and organ growth. Derangement of RTKs-by mutation or by overexpression-is central to several developmental and adult disorders including cancer, short stature, and vascular pathologies. The mechanism of action of RTKs is complex and is regulated by contextual components, including the existence of multiple competing ligands and receptors in many families, the intracellular location of the RTK, the dynamic and cell-specific coexpression of other RTKs, and the commonality of downstream signaling pathways. This means that both the state of the cell and the microenvironment outside the cell play a role, which makes sense given the pivotal location of RTKs as the nexus linking the extracellular milieu to intracellular signaling and modification of cell behavior. In this review, we describe these different contextual components through the lens of systems biology, in which both computational modeling and experimental "omics" approaches have been used to better understand RTK networks. The complexity of these networks is such that using these systems biology approaches is necessary to get a handle on the mechanisms of pathology and the design of therapeutics targeting RTKs. In particular, we describe in detail three concrete examples (involving ErbB3, VEGFR2, and AXL) that illustrate how systems approaches can reveal key mechanistic and therapeutic insights. This article is categorized under: Biological Mechanisms > Cell Signaling Models of Systems Properties and Processes > Mechanistic Models Translational, Genomic, and Systems Medicine > Therapeutic Methods
引用
收藏
页数:16
相关论文
共 110 条
[1]   VEGF internalization is not required for VEGFR-2 phosphorylation in bioengineered surfaces with covalently linked VEGF [J].
Anderson, Sean M. ;
Shergill, Bhupinder ;
Barry, Zachary T. ;
Manousiouthakis, Eleana ;
Chen, Tom T. ;
Botvinick, Elliot ;
Platt, Manu O. ;
Iruela-Arispe, M. Luisa ;
Segura, Tatiana .
INTEGRATIVE BIOLOGY, 2011, 3 (09) :887-896
[2]   Feedback regulation of EGFR signalling: decision making by early and delayed loops [J].
Avraham, Roi ;
Yarden, Yosef .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2011, 12 (02) :104-117
[3]   Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output [J].
Ballmer-Hofer, Kurt ;
Andersson, Anneli E. ;
Ratcliffe, Laura E. ;
Berger, Philipp .
BLOOD, 2011, 118 (03) :816-826
[4]   Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 [J].
Baselga, Jose ;
Swain, Sandra M. .
NATURE REVIEWS CANCER, 2009, 9 (07) :463-475
[5]   Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase [J].
Bell, CA ;
Tynan, JA ;
Hart, KC ;
Meyer, AN ;
Robertson, SC ;
Donoghue, DJ .
MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (10) :3589-3599
[6]   Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction [J].
Bergeron, John J. M. ;
Di Guglielmo, Gianni M. ;
Dahan, Sophie ;
Dominguez, Michel ;
Posner, Barry I. .
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85, 2016, 85 :573-597
[7]   Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses [J].
Birtwistle, Marc R. ;
Hatakeyama, Mariko ;
Yumoto, Noriko ;
Ogunnaike, Babatunde A. ;
Hoek, Jan B. ;
Kholodenko, Boris N. .
MOLECULAR SYSTEMS BIOLOGY, 2007, 3 (1)
[8]   Dynamic alterations in decoy VEGF receptor-1 stability regulate angiogenesis [J].
Boucher, Joshua M. ;
Clark, Ryan P. ;
Chong, Diana C. ;
Citrin, Kathryn M. ;
Wylie, Lyndsay A. ;
Bautch, Victoria L. .
NATURE COMMUNICATIONS, 2017, 8
[9]   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583
[10]   Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2 [J].
Chandler, Kevin Brown ;
Leon, Deborah R. ;
Meyer, Rosana D. ;
Rahimi, Nader ;
Costello, Catherine E. .
JOURNAL OF PROTEOME RESEARCH, 2017, 16 (02) :677-688